The compounds targeting histone deacetylase, JAK/STAT, histone demethylases, and aurora kinase pathways—specifically panobinostat, pacritinib, TAK-901, and JIB-04—showed significant tumor-killing effects on TNBC. This evidence concerns the gene SOAT1 and neoplasm.